Table of Contents
Basic Research
| Promotion of MAG-1 on Metastasis of Lung Cancer Cells in vitro and Its Expression in Lung Cancer Tissue of 24 Cases | PDF HTML |
| Jinqiang ZHANG, Yuhong MENG, Huiyun LIN, Gang LIU, Yan WANG, Huihua CHEN, Yuanji XU, Zhiyan DU, Yinglin LU | 93-99 |
| The Effects of Interfering COX-2 Gene Expression on Malignant Proliferation of Human Lung Adenocarcinoma A2 Cell in vitro | PDF HTML |
| Weiying Li, Hui WANG, Baitang LAI, Xuehui YANG, Chunyan ZHANG | 100-105 |
| The Recovery Process of Murine Tracheal Epithelium Injured by 5-FU and Its Microarray Analysis | PDF HTML |
| Jingru ZHANG, Nan SONG, Xinshan JIA, Shanliang SUN, Xiaobo MA, Enhua WANG | 106-110 |
Clinical Research
| The Relationship between TSG101 Protein and Notch3 Receptor in Lung Cancer | |
| Jiahui CHANG, Ping LU, Cunwei CAI, Fei LI, Zhiyong ZHONG, Daorong ZHANG | 111-116 |
| Expression of DLL4 and VEGF in Lung Adenocarcinoma and their Relationship with Angiogenesis in Tumor | |
| Xiaoping LI, Qingfu ZHANG, Bin LU, Xueshan QIU, Yang LUO, Weidong ZHANG, Shun XU | 117-121 |
| The Retrospective Analysis of Different Therapies on 150 Elderly Patients with Advanced Non-Small Cell Lung Cancer | |
| Jihua ZHENG, Weimin ZHANG, Hai CHEN, Zhiyong XU, Juan ZHOU, Bo XIE, Lixia LI, Jinrong LIN | 122-126 |
| The Role of Thyroid Transcription Factor-1 DNA Binding Activity in Lung Cancer | |
| Zongwei GAO, Chunbao GUO, Xianqing JIN | 127-130 |
| Expression of FHIT Protein in Lung Cancer by Cell Array | |
| Xinyun WANG, Ling YUAN, Haiyan ZHENG, Juan LIU, Xi HUANG, Li WU, Haihong YUAN, Jianlan ZHAO | 131-134 |
| Sequential Changes of Serum Tumor Markers Before and After the Radioactive 125I-seed Implantation in the Treatment of Lung Cancer | |
| Gang DAN, Jing JIN, Wei LI, Rong LU, Tiejun ZHAO, Hangfeng ZHAO | 135-138 |
| Rigid Bronchoscope Combined with Soft Electronic Bronchoscope for Treatment of Main Airway Neoplasma | |
| Hongwu WANG, Yunzhi ZHOU, Heng ZOU, Jing LI | 139-142 |
Minireview
| Human FLJ20420 and Its Bio-Functions | |
| Baoxing LIU, Hongyu LIU, Jun CHEN, Qinghua ZHOU | 143-146 |
| Advances of HIF-1 alpha and Its Role in Lung Cancer | |
| Yang LV, Peng ZHANG | 147-151 |
| The Application of Decellularized Matrices in the Tissue Engineering of Vascular Graft | |
| Jiande DONG, Jian ZHANG, Yongquan GU | 152-155 |
| The Biologic Characteristics and Treatment of Non-Small Cell Lung Cancer in Non Smokers | |
| Rong QIAO, Baohui HAN | 156-161 |
| 18F-FDG PET/ CT in Staging of Lung Cancer | |
| Peng XIE, Weiwei ZHAO, Houfu DENG | 162-164 |
Meeting Report
| Advances in Bevacizumab Therapy of Primary Lung Cancer | |
| Jun PEI, Baohui HAN | 165-171 |
Short Communications
| The Correlation between FDG PET/CT Imaging and Molecule Makers in Non-Small Cell Lung Cancer | |
| Mi ZHOU, Tingting SUN, Xiaobo XING, Jinxia YANG | 172-175 |
| Comparison of Oral Topotecan/Intravenous Cisplatin (TC) with Intravenous Etoposide/ Cisplatin (EP) as First Line Chemotherapy in Untreated Small Cell Lung Cancer Patient | |
| Qiyi MENG, Yunzhong ZHU, Shucai ZHANG, Liyan XU, Zhe LIU, Yonghong YOU, Junfang TANG | 176-178 |
Case Reports
| Surgical Treatment of Synchronous Lung Cancer and Hepatic Metastasis | |
| Yi ZHANG, Xiang WEI, Tiecheng PAN | 179-182 |
